Tirzepatide
Tirzepatide is a pharmaceutical drug with 173 clinical trials. Currently 85 active trials ongoing. Historical success rate of 98.2%.
Success Metrics
Based on 56 completed trials
Phase Distribution
Phase Distribution
32
Early Stage
51
Mid Stage
68
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
93.3%
56 of 60 finished
6.7%
4 ended early
85
trials recruiting
173
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
GLP-1R Actions on Muscle and the Skeleton
A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight
Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Clinical Trials (173)
GLP-1R Actions on Muscle and the Skeleton
A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight
Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without Diabetes
A Study of a Weight Loss Intervention in People With Endometrial Cancer
A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
Bariatric Surgery vs. Semaglutide vs. Tirzepatide
Tirzepatide in MetALD
Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity
Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity
Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese
A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 173